Università Vita-Salute San Raffaele (UniSR)

Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer (2025) Hoeppner J, Brunner T, Schmoor C, Bronsert P, Kulemann B, Claus R, Utzolino S, et al. Journal article The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early breast cancer-a multidisciplinary consensus. (2025) Pfob A, Pinker K, Vaz-Luis I, Di Meglio A, Cardoso MJ, Curigliano G, Gentilini OD, et al. Journal article, Review article Endoscopic papillectomy for laterally spreading lesions of the papilla: a propensity score-matched analysis (2025) Vu Trung K, Abou-Ali E, Gulla A, Soares K, Caillol F, Paik WH, Napoleon B, et al. Journal article An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease (2025) Hanžel J, Solitano V, Vuyyuru SK, Panaccione R, Sands BE, Peyrin-Biroulet L, Danese S, et al. Journal article Consensus on acromegaly therapeutic outcomes: an update (2025) Melmed S, di Filippo L, Fleseriu M, Mercado M, Karavitaki N, Gurnell M, Salvatori R, et al. Journal article Development and validation of the SDLD score: a simplified tool to predict successful endoscopic papillectomy in ampullary lesions (2025) Vu Trung K, Abou-Ali E, Gulla A, Soares K, Caillol F, Paik WH, Napoleon B, et al. Journal article Interstitial lung disease in anti-U1RNP systemic sclerosis patients: A European Scleroderma Trials and Research analysis (2025) Boleto G, Campochiaro C, Distler O, Balanescu A, Launay D, Bergmann C, Airò P, et al. Journal article Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial (2025) Powles T, Tagawa S, Vulsteke C, Gross-Goupil M, Park SH, Necchi A, De Santis M, et al. Journal article Gastric neuroendocrine neoplasms (2024) Lamberti G, Panzuto F, Pavel ME, O’Toole D, Ambrosini V, Falconi M, Garcia-Carbonero R, et al. Journal article Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials (2024) Peyrin‐Biroulet L, Arkkila P, Armuzzi A, Danese S, Ferrante M, Jordi Guardiola , Jahnsen J, et al. Journal article